Exploratory Study of Autoantibody Profiling in Drug‐Induced Liver Injury with an Autoimmune Phenotype

Craig Lammert, Chengsong Zhu, Yun Lian, Indu Raman, George Eckert, Quan‐Zhen Li, Naga Chalasani – 1 September 2020 – Drug‐induced liver injury (DILI) sometimes presents with an autoimmune hepatitis‐like phenotype (AI‐DILI), and it is challenging to distinguish it from de novo autoimmune hepatitis (AIH). We conducted a study to identify autoantibodies unique to AI‐DILI by profiling serum autoantibodies.

Time to Conversion to an Everolimus‐Based Regimen: Renal Outcomes in Liver Transplant Recipients From the EVEROLIVER Registry

Faouzi Saliba, Sébastien Dharancy, Ephrem Salamé, Filoména Conti, Daniel Eyraud, Sylvie Radenne, Térésa Antonini, Olivier Guillaud, Jean Guguenheim, Martine Neau‐Cransac, Eléonora Demartin, Guillaume Lasailly, Christophe Duvoux, Rodolphe Sobesky, Audrey Coilly, Sylvie Tresson, Valérie Cailliez, Olivier Boillot, Georges Philippe Pageaux, Didier Samuel, Yvon Calmus, Jérôme Dumortier – 31 August 2020 – Longterm use of a calcineurin inhibitor (CNI)–based regimen is one of the major reasons for chronic renal failure in liver transplantation recipients (LTRs).

Reply:

Andrew J. Brooks, Mayumi Ishikawa, Manuel A. Fernández‐Rojo, Julian P. Vivian, Jamie Rossjohn, Michael J. Waters – 31 August 2020

Precore and Basal Core Promoter Hepatitis B Virus (HBV) Variants Are Present From a Young Age and Differ Across HBV Genotypes

Daryl T.Y. Lau, Lilia Ganova‐Raeva, Junyao Wang, Douglas Mogul, Raymond T. Chung, Mauricio Lisker‐Melman, Kyong‐Mi Chang, Obaid S. Shaikh, Harry L.A. Janssen, Abdus S. Wahed, Anna S. Lok, for the Hepatitis B Research Network – 29 August 2020

Subscribe to